Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization

Clinical trial NCT02033018 · UNKNOWN

Trial details

NCT number: NCT02033018
Sponsor: Instituto de Olhos de Goiania
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Choroidal Retinal Neovascularization

Start date: 2013-10-01
Primary completion: 2014-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.